- Discover ITHS
- About ITHS
- About Translational Research
- Leadership
- ITHS Cores
- Administration
- Biomedical Informatics
- Center for Biomedical Statistics
- Center for Scientific Review
- Clinical Research Center Network
- Community Outreach and Research Translation
- Evaluation Research
- Preclinical Research Development Network
- Regulatory Support and Bioethics
- Research Education, Training, & Career Dev.
- Strategic Development
- Translational Technologies and Resources
- WWAMI Translational Research Consortium
- Regional Partnerships
- Accomplishments
- Request a CONSULT
- Find a RESOURCE
- Get FUNDING
- Find TRAINING
- Find PEOPLE
- Get INVOLVED
Therapeutic Manufacturing Gene and Cell Therapy Laboratory

The Gene and Cell Therapy Lab (GCTC) provides translational researchers with the infrastructure, education, and technical expertise necessary to develop novel gene and cell based clinical products for therapeutic applications.
We assist investigators throughout the process, from the research benchtop, through regulatory communications, to the manufacture of products and infusion of volunteer subjects at the UW CRC.
To ensure the highest attainable level of participant safety, we conduct all activities under a comprehensive quality assurance program that is compliant with current Good Manufacturing Practices (cGMP).
Facilities
The GCTC Lab is located on the UW CRC, facilitating the transfer of patient samples between the clinic and the laboratory. The lab is composed of four secure access critical environment suites (two Biosafety Level 2 suites and two BL3). To prevent cross-contamination of products, each suite is outfitted with dedicated equipment, including biosafety cabinets, incubators, centrifuges and microscopes.
Services
The GCTC lab provides:
- Trained GCTC scientific staff
- Training of investigator staff in cGMP
- Assistance in manufacturing protocol design
- Assistance in writing and submitting Investigational New Drug Applications (INDs) to FDA
- Development of Standard Operating Procedures
- Facility equipment maintenance to comply with regulatory requirements
- Documentation and regulatory support
- Secure archiving of study samples
- Quality Assurance oversight
Investigators provide reagents, biologics and disposables needed for their clinical trial, protocol-specific equipment not available in the GCTC Lab, and technical personnel to assist in manufacturing.
How researchers use this resource or service
The GCTC laboratory has manufactured clinical cell products for a number of diverse investigator INDs. These include:
- A Phase I Study of HER-2/neu Specific T Cells in Patients with Advanced Stage HER-2/neu Expressing Cancers who Have Received a HER-2/neu Vaccine.
- Production and Testing of a new Lot of Bacteriophage PhiX174 antigen (FDA BBIND 714) for Clinical Use.
- A Phase I Study to Evaluate the Safety and Feasibility of Cellular Immunotherapy Using Genetically Modified Autologous CD20-Specific T cells for Patients with Relapsed or Refractory Mantle Cell and Indolent B cell Lymphomas
- A Phase I Study of Dose-Intensive Chemotherapy in Combination with Chemoprotected Autologous Stem Cells for Patients with Malignant Gliomas
- Bone Marrow-Derived Stem Cells for End-Stage Ischemic Cardiomyopathy
Fees
We are a fee for service core. Investigators planning to use our services must work with the Nutrition Researcher Manager to plan a budget for any grant or proposal submission.
Manufacturing done in a cGMP-compliant clean room facility are decidedly more labor-intensive and expensive than traditional pre-clinical laboratory bench-top work. Developing a protocol budget with the GCTC prior to submitting grant proposals is strongly suggested.
Read more about University of Washington CRC Services fees.
Getting started
Read getting started at the UW CRC for details on where to begin. If you have any questions,contact Cathy Lindgren.
Last modified: January 4, 2010